2877.HK
SHINEWAY PHARM
HK$8.38
+2.07%
2026-05-29
About SHINEWAY PHARM
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.
Key Fundamentals
P/E Ratio
6.42
Forward P/E
5.70
EPS (TTM)
HK$1.45
ROE
12.2%
Revenue Growth (YoY)
-12.3%
Profit Margin
30.3%
Debt/Equity
4.15
Dividend Yield
6.5%
Price/Book
0.76
Beta
0.83
Market Cap
HK$7.03B
Avg Volume (10D)
871K
Recent Breakout Signals
No recent breakout signals detected for 2877.HK.
Recent Price Range (60 Days)
60D High
HK$10.47
60D Low
HK$8.14
Avg Volume
1.1M
Latest Close
HK$8.38
Get breakout alerts for 2877.HK
Sign up for Breakout Scanner to receive daily notifications when 2877.HK triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
SHINEWAY PHARM (2877.HK) is listed on the Hong Kong Exchanges (HKEX). Breakout Scanner monitors 2877.HK daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. 2877.HK operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry. Data is provided for informational purposes only and does not constitute financial advice.